Prognostic significance of combined conventional and immunocytochemical cytology for peritoneal washings in endometrial carcinoma

Cancer

Volumn 93, Issue 2, 2001, Pages 115-123

  Luo, Ming Liang ^a   Sakuragi, Noriaki ^a,c   Shimizu, Michio ^a   Seino, Kuniyoshi ^b   Okamoto, Kazuhira ^a   Kaneuchi, Masanori ^b   Ebina, Yasuhiko ^a   Okuyama, Kazuhiko ^a   Fujino, Takafumi ^b   Sagawa, Tadashi ^a   Fujimoto, Seiichiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^c Hokkaido Cancer Society   (Japan)

Author keywords

Endometrial carcinoma; Immunocytochemistry; MOC 31; P53; Peritoneal cytology; Survival

Indexed keywords

CD45 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKERATIN; DOXORUBICIN; MONOCLONAL ANTIBODY; PROTEIN P53;

ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER GRADING; CELL TRANSFER; CONTROLLED STUDY; CYTODIAGNOSIS; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY METASTASIS; PAPANICOLAOU TEST; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MIDDLE AGED; PERITONEUM; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035048510     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.9017     Document Type: Article

References (26)

1. FIGO news, Corpus cancer staging
2. The prognostic value of peritoneal cytology in gynecologic malignant disease
3. Relationship between surgical-pathological risk factors and outcome in clinical Stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study
4. Malignant peritoneal cytology as prognostic indicator in Stage I endometrial cancer
5. Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium
6. Prognostic value of peritoneal cytology in endometrial carcinoma
7. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease
8. Post-operative peritoneal washing cytology in cases of Stage IIIa endometrial carcinoma with positive peritoneal cytology
9. Immunocytology of body cavity fluids. MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells
10. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas
11. Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: A population-based endometrial carcinoma study
12. p53 expression as a prognostic indicator of 5-year survival in endometrial cancer
13. p53 gene product in pleural effusions. Practical use in distinguishing benign from malignant cells
14. Peritoneal cytology and its prognostic value in endometrial carcinoma
15. Immunostaining of small cytologic specimens: Facilitation with cell transfer
16. Cell transfer technique with Malinol mounting medium: An application to immunocytochemistry and ISH methods
17. The role of conventional cytology, immunocytochemistry, and flow cytometric DNA ploidy in the evaluation of body cavity fluids: A prospective study of 52 patients
18. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma
19. Evaluation of immunocytochemical staining as a method of improving diagnostic accuracy in a routine cytopathology laboratory
20. Monoclonal antibodies in the cytodiagnosis of serous effusions
21. A comparison between the preoperative and operative findings of peritoneal cytology in patients with endometrial cancer
22. Cox multivariate regression models for estimating prognosis of patients with endometrioid adenocarcinoma of uterine corpus who underwent thorough surgical staging
23. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma
24. Peritoneal washings in endometrial carcinoma. A study of 298 patients with histopathologic correlation
25. Uterine papillary serous carcinoma: Patterns of metastatic spread